Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems

Zheng Chen, Seung Hee Yoo, Joseph S. Takahashi

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Circadian timekeeping systems drive oscillatory gene expression to regulate essential cellular and physiological processes. When the systems are perturbed, pathological consequences ensue and disease risks rise. A growing number of small-molecule modulators have been reported to target circadian systems. Such small molecules, identified via high-throughput screening or derivatized from known scaffolds, have shown promise as drug candidates to improve biological timing and physiological outputs in disease models. In this review, we first briefly describe the circadian system, including the core oscillator and the cellular networks. Research progress on clock-modulating small molecules is presented, focusing on development strategies and biological efficacies. We highlight the therapeutic potential of small molecules in clock-related pathologies, including jet lag and shiftwork; various chronic diseases, particularly metabolic disease; and aging. Emerging opportunities to identify and exploit clock modulators as novel therapeutic agents are discussed.

Original languageEnglish (US)
Pages (from-to)231-252
Number of pages22
JournalAnnual Review of Pharmacology and Toxicology
Volume58
DOIs
StatePublished - Jan 6 2018

Fingerprint

Modulators
Physiological Phenomena
Clocks
Molecules
Metabolic Diseases
Chronic Disease
Pathology
Gene Expression
Therapeutics
Research
Gene expression
Scaffolds
Pharmaceutical Preparations
Screening
Aging of materials
Throughput

Keywords

  • aging
  • chemical derivatization
  • chronotherapy
  • circadian clock
  • clock-related diseases
  • high-throughput screen

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems. / Chen, Zheng; Yoo, Seung Hee; Takahashi, Joseph S.

In: Annual Review of Pharmacology and Toxicology, Vol. 58, 06.01.2018, p. 231-252.

Research output: Contribution to journalReview article

@article{ade1a939eff0490d9fffa73aca952b96,
title = "Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems",
abstract = "Circadian timekeeping systems drive oscillatory gene expression to regulate essential cellular and physiological processes. When the systems are perturbed, pathological consequences ensue and disease risks rise. A growing number of small-molecule modulators have been reported to target circadian systems. Such small molecules, identified via high-throughput screening or derivatized from known scaffolds, have shown promise as drug candidates to improve biological timing and physiological outputs in disease models. In this review, we first briefly describe the circadian system, including the core oscillator and the cellular networks. Research progress on clock-modulating small molecules is presented, focusing on development strategies and biological efficacies. We highlight the therapeutic potential of small molecules in clock-related pathologies, including jet lag and shiftwork; various chronic diseases, particularly metabolic disease; and aging. Emerging opportunities to identify and exploit clock modulators as novel therapeutic agents are discussed.",
keywords = "aging, chemical derivatization, chronotherapy, circadian clock, clock-related diseases, high-throughput screen",
author = "Zheng Chen and Yoo, {Seung Hee} and Takahashi, {Joseph S.}",
year = "2018",
month = "1",
day = "6",
doi = "10.1146/annurev-pharmtox-010617-052645",
language = "English (US)",
volume = "58",
pages = "231--252",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0362-1642",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems

AU - Chen, Zheng

AU - Yoo, Seung Hee

AU - Takahashi, Joseph S.

PY - 2018/1/6

Y1 - 2018/1/6

N2 - Circadian timekeeping systems drive oscillatory gene expression to regulate essential cellular and physiological processes. When the systems are perturbed, pathological consequences ensue and disease risks rise. A growing number of small-molecule modulators have been reported to target circadian systems. Such small molecules, identified via high-throughput screening or derivatized from known scaffolds, have shown promise as drug candidates to improve biological timing and physiological outputs in disease models. In this review, we first briefly describe the circadian system, including the core oscillator and the cellular networks. Research progress on clock-modulating small molecules is presented, focusing on development strategies and biological efficacies. We highlight the therapeutic potential of small molecules in clock-related pathologies, including jet lag and shiftwork; various chronic diseases, particularly metabolic disease; and aging. Emerging opportunities to identify and exploit clock modulators as novel therapeutic agents are discussed.

AB - Circadian timekeeping systems drive oscillatory gene expression to regulate essential cellular and physiological processes. When the systems are perturbed, pathological consequences ensue and disease risks rise. A growing number of small-molecule modulators have been reported to target circadian systems. Such small molecules, identified via high-throughput screening or derivatized from known scaffolds, have shown promise as drug candidates to improve biological timing and physiological outputs in disease models. In this review, we first briefly describe the circadian system, including the core oscillator and the cellular networks. Research progress on clock-modulating small molecules is presented, focusing on development strategies and biological efficacies. We highlight the therapeutic potential of small molecules in clock-related pathologies, including jet lag and shiftwork; various chronic diseases, particularly metabolic disease; and aging. Emerging opportunities to identify and exploit clock modulators as novel therapeutic agents are discussed.

KW - aging

KW - chemical derivatization

KW - chronotherapy

KW - circadian clock

KW - clock-related diseases

KW - high-throughput screen

UR - http://www.scopus.com/inward/record.url?scp=85040596128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040596128&partnerID=8YFLogxK

U2 - 10.1146/annurev-pharmtox-010617-052645

DO - 10.1146/annurev-pharmtox-010617-052645

M3 - Review article

C2 - 28968186

AN - SCOPUS:85040596128

VL - 58

SP - 231

EP - 252

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0362-1642

ER -